Organogenesis of peripheral lymphoid organs

Immunological Reviews

Volumn 195, Issue , 2003, Pages 72-80

  Nishikawa, Shin Ichi ^a   Honda, Kenya ^b   Vieira, Paul ^c   Yoshida, Hisahiro ^d  

^a RIKEN Center for Biosystems Dynamics Research   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c INSTITUT PASTEUR   (France)

^d RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 7; LYMPHOTOXIN; VASCULAR CELL ADHESION MOLECULE 1;

CELLULAR DISTRIBUTION; HEMATOPOIETIC SYSTEM; KNOCKOUT MOUSE; LYMPHOID ORGAN; MESENCHYME CELL; NONHUMAN; ORGANOGENESIS; PEYER PATCH; PRIORITY JOURNAL; REVIEW;

ANIMALS; INTERLEUKIN-7; LYMPH NODES; LYMPHOTOXIN-ALPHA; ORGANOGENESIS; PEYER'S PATCHES;

EID: 0141678839     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2003.00063.x     Document Type: Review

References (46)

1. Ansel KM, Cyster JG. Chemokines in lymphopoiesis and lymphoid organ development. Curr Opin Immunol 2001;13:172-179.
2. - cells in lymphoid organ development. Immunol Rev 2002;189:41-50.
3. - cells induce Peyer's patch development: role of alpha4beta1 integrin activation by CXCR5. Immunity 2002;17:363-373.
4. Finke D, Kraehenbuhl JP. Formation of Peyer's patches. Curr Opin Genet Dev 2001;11:561-567.
5. Fu YX, Chaplin DD. Development and maturation of secondary lymphoid tissues. Annu Rev Immunol 1999;17:399-433.
6. Muller G, Lipp M. Concerted action of the chemokine and lymphotoxin system in secondary lymphoid-organ development. Curr Opin Immunol 2003;15:217-224.
7. Nishikawa SI, Hashi H, Honda K, Fraser S, Yoshida H. Inflammation, a prototype for organogenesis of the lymphopoietic/hematopoietic system. Curr Opin Immunol 2000;12:342-345.
8. Nishikawa S, Honda K, Hashi H, Yoshida H. Peyer's patch organogenesis as a programmed inflammation: a hypothetical model. Cytokine Growth Factor Rev 1998;9:213-220.
9. + CD3(-) cells in the embryonic intestine induces the organizing center of Peyer's patches. Int Immunol 1999;11:643-655.
10. Honda K, et al. Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis. J Exp Med 2001;193:621-630.
11. - cells, as well as macrophages. J Immunol 2001;166:6593-6601.
12. Yoshida H, et al. Expression of alpha (4) beta (7) integrin defines a distinct pathway of lymphoid progenitors committed to T cells, fetal intestinal lymphotoxin producer, NK, and dendritic cells. J Immunol 2001;167:2511-2521.
13. Adachi S, et al. Essential role of IL-7 receptor alpha in the formation of Peyer's patch anlage. Int Immunol 1998;10:1-6.
14. Alimzhanov MB, et al. Abnormal development of secondary lymphoid tissues in lymphotoxin beta-deficient mice. Proc Natl Acad Sci USA 1997;94:9302-9307.
15. Ansel KM, et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000;406:309-314.
16. Banks TA, et al. Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol 1995;155:1685-1693.
17. De Togni P, et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 1994;264:703-707.
18. Futterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 1998;9:59-70.
19. Koni PA, Sacca R, Lawton P, Browning JL, Ruddle NH, Flavell RA. Distinct roles in lymphoid organogenesis for lymphotoxins alpha and beta revealed in lymphotoxin beta-deficient mice. Immunity 1997;6:491-500.
20. Mebius RE, Rennert P, Weissman IL. Developing lymph nodes collect CD4+CD3-LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 1997;7:493-504.
21. Yoshida H, et al. Different cytokines induce surface lymphotoxin-alphabeta on IL-7 receptor-alpha cells that differentially engender lymph nodes and Peyer's patches. Immunity 2002;17:823-833.
22. Dougall WC, et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999;13:2412-2424.
23. Kim D, et al. Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J Exp Med 2000;192:1467-1478.
24. Kong YY, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999;397:315-323.
25. Sims JE, et al. Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J Exp Med 2000;192:671-680.
26. Pandey A, et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat Immun 2000;1:59-64.
27. Park LS, et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor. J Exp Med 2000;192:659-670.
28. Isaksen DE, Baumann H, Trobridge PA, Farr AG, Levin SD, Ziegler SF. Requirement for stat5 in thymic stromal lymphopoietin-mediated signal transduction. J Immunol 1999;163:5971-5977.
29. Sekimoto T, et al. Region-specific expression of murine Hox genes implies the Hox code-mediated patterning of the digestive tract. Genes Cells 1998;3:51-64.
30. Kondo S. The reaction-diffusion system: a mechanism for autonomous pattern formation in the animal skin. Genes Cells 2002;7:535-541.
31. Turing A. The chemical basis of morphogenesis. Philos Trans R Soc Lond B 1952;B327:37-72.
32. Kondo S, Asai R. A reaction-diffusion wave on the skin of the marine angelfish pomacanthus. Nature 1995;376:765-768.
33. Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS. Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs. J Exp Med 1996;184:1999-2006.
34. Fujihashi K, et al. Peyer's patches are required for oral tolerance to proteins. Proc Natl Acad Sci USA 2001;98:3310-3315.
35. Rennert PD, et al. Essential role of lymph nodes in contact hypersensitivity revealed in lymphotoxin-alpha-deficient mice. J Exp Med 2001;193:1227-1238.
36. Rennert PD, James D, Mackay F, Browning JL, Hochman PS. Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity 1998;9:71-79.
37. Ettinger R, Browning JL, Michie SA, van Ewijk W, McDevitt HO. Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein. Proc Natl Acad Sci USA 1996;93:13102-13107.
38. Bailey RP, Weiss L. Ontogeny of human fetal lymph nodes. Am J Anat 1975;142:15-27.
39. Eikelenboom P, Nassy JJ, Post J, Versteeg JC, Langevoort HL. The histogenesis of lymph nodes in rat and rabbit. Anat Rec 1978;190:201-215.
40. Kaipainen A, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995;92:3566-3570.
41. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999;98:769-778.
42. Wigle JT, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 2002;21:1505-1513.
43. Makinen T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 2001;7:199-205.
44. Stacker SA, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001;7:186-191.
45. Skobe M, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7:192-198.
46. Hashi H, et al. Compartmentalization of Peyer's patch anlagen before lymphocyte entry. J Immunol 2001;166:3702-3709.